Mario Gruppo
Papers
2
Total Citations
5
H-Index
2
About
Mario Gruppo is a surgical oncologist whose research centers on the optimization of pancreatic and periampullary cancer surgery, with a particular focus on minimally invasive techniques and prognostic factors. His most cited work, a 2024 propensity score-matched international multicenter cohort study, rigorously compared oncological resection and perioperative outcomes of robotic, laparoscopic, and open pancreatoduodenectomy for ampullary adenocarcinoma, providing critical evidence for the safety and efficacy of minimally invasive approaches in this challenging procedure. This study, already garnering 3 citations, underscores his role in advancing surgical decision-making through large-scale, collaborative data. Additionally, his 2017 investigation into para-aortic node involvement in pancreatic cancer challenged conventional prognostic assumptions, demonstrating that such nodal spread is not an independent predictor of survival after resection—a finding that has informed surgical staging and patient counseling. Through these contributions, Gruppo has helped refine both the technical and prognostic frameworks of pancreatic surgery, influencing how surgeons evaluate and treat these complex malignancies.
Research Focus
Key Achievements
Top Papers
- 1
- 2